Allergen, Individual-Food Beef Cow meat (Bos spp.) F27

The Allergen, Individual-Food Beef Cow Meat (Bos spp.) F27 is an at-home blood test that measures specific IgE antibodies to beef (cow meat) proteins, indicating sensitization to bovine meat. A small serum sample is analysed in an accredited laboratory to quantify sIgE (reported in kUA/L) and classify sensitization levels, helping to clarify whether immune-mediated reactions to beef are likely.

This test is useful for individuals who experience immediate allergic symptoms after consuming beef (hives, angioedema, wheeze, vomiting, or anaphylaxis), for unexplained chronic urticaria or GI reactions, and for those planning dietary elimination or allergy management. Performed across Dubai and the UAE with at‑home collection options, results support safe dietary decisions and guide further evaluation by an allergist or treating physician.

Results typically report the numeric sIgE concentration and an allergy class (e.g., 0–6) with laboratory reference ranges; turnaround time depends on the chosen laboratory but is usually within a few days. Note that a positive sensitization result does not always confirm clinical allergy — correlation with symptoms, supervised oral food challenges, or specialist consultation may be required before changing treatment or diet.

• Beef (cow meat) (Bos spp.) specific IgE (sIgE)
• Result concentration (kUA/L)
• Allergy sensitization class (0–6)
• Sample type: Serum

• Immediate allergic reaction after eating beef (hives, swelling, breathing difficulty)
• Recurrent unexplained urticaria or angioedema
• Gastrointestinal symptoms (vomiting, abdominal pain) following beef consumption
• History of anaphylaxis or suspected red-meat allergy
• Before starting or adjusting an elimination diet or allergy management plan

• Identifies sensitization to beef proteins to inform safe dietary choices
• Convenient at-home blood collection across Dubai and the UAE
• Quantitative results to track changes or guide specialist referral
• Reduces risk of accidental exposure by clarifying allergy status
• Reports compatible with clinician review for follow-up care

• At‑home blood sample collection (venous serum) by a trained phlebotomist
• No fasting required prior to sample collection
• Inform the collector/clinic about recent allergen immunotherapy or anti-IgE therapy (e.g., omalizumab)
• Provide Emirates ID and relevant clinical history for lab reporting